Caraco Pharmaceutical Laboratories

caraco

Caraco Stockholders Approve Merger With Parent Sun Pharma

Detroit-based Caraco Pharmaceutical Laboratories Inc. will shortly cease operation as a publicly traded company.

WWJ Newsradio 950–06/14/2011

caraco

Caraco Loss Flat Despite Lower Sales

The Detroit generic drug maker Caraco Pharmaceutical reported a loss of $3 million or eight cents a share in the third fiscal quarter of its fiscal year, ended Dec. 31, an improvement from a loss of $3.3 million or eight cents a share in the same quarter a year earlier despite a decline in revenue in the quarter to $40.4 million from $52 million a year earlier.

01/30/2011

Caraco Pharmaceutical Names New CEO

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) announced last week that G. P. Singh Sachdeva will assume the position of CEO following the resignation of Jitendra N. Doshi as interim CEO and director as […]

10/10/2010

Caraco Adds Two Generics

Detroit-based Caraco Pharmaceutical Laboratories Ltd. (NYSE Amex: CPD) announced that it has started shipping azelastine ophthalmic solution, 0.05 percent, and rivastigmine tartrate capsules.

07/18/2010

Follow

Get every new post delivered to your Inbox.

Join 1,975 other followers